nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—psoriasis	0.0929	0.145	CbGbCtD
Zaleplon—CYP3A5—Beclomethasone—psoriasis	0.088	0.137	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0375	0.0585	CbGbCtD
Zaleplon—CYP3A7—Hydrocortisone—psoriasis	0.0375	0.0585	CbGbCtD
Zaleplon—CYP3A7—Cyclosporine—psoriasis	0.0354	0.0553	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0354	0.0553	CbGbCtD
Zaleplon—CYP3A5—Mycophenolate mofetil—psoriasis	0.035	0.0547	CbGbCtD
Zaleplon—CYP3A4—Calcitriol—psoriasis	0.0306	0.0478	CbGbCtD
Zaleplon—CYP3A5—Hydrocortisone—psoriasis	0.0281	0.0439	CbGbCtD
Zaleplon—CYP3A5—Cyclosporine—psoriasis	0.0266	0.0415	CbGbCtD
Zaleplon—CYP3A4—Methoxsalen—psoriasis	0.0238	0.0371	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0233	0.0364	CbGbCtD
Zaleplon—CYP3A7—Dexamethasone—psoriasis	0.0233	0.0364	CbGbCtD
Zaleplon—CYP3A5—Dexamethasone—psoriasis	0.0175	0.0273	CbGbCtD
Zaleplon—CYP3A4—Cholecalciferol—psoriasis	0.0158	0.0246	CbGbCtD
Zaleplon—CYP3A4—Mycophenolate mofetil—psoriasis	0.0137	0.0213	CbGbCtD
Zaleplon—CYP3A4—Triamcinolone—psoriasis	0.0137	0.0213	CbGbCtD
Zaleplon—CYP3A4—Betamethasone—psoriasis	0.0117	0.0183	CbGbCtD
Zaleplon—CYP3A4—Prednisolone—psoriasis	0.0116	0.0181	CbGbCtD
Zaleplon—CYP3A4—Hydrocortisone—psoriasis	0.011	0.0171	CbGbCtD
Zaleplon—CYP3A4—Prednisone—psoriasis	0.0109	0.0171	CbGbCtD
Zaleplon—CYP3A4—Cyclosporine—psoriasis	0.0104	0.0162	CbGbCtD
Zaleplon—CYP3A4—Dexamethasone—psoriasis	0.00682	0.0106	CbGbCtD
Zaleplon—Stomatitis—Methotrexate—psoriasis	9.84e-05	0.000273	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—psoriasis	9.81e-05	0.000273	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.81e-05	0.000273	CcSEcCtD
Zaleplon—Immune system disorder—Prednisone—psoriasis	9.79e-05	0.000272	CcSEcCtD
Zaleplon—Malaise—Dexamethasone—psoriasis	9.77e-05	0.000272	CcSEcCtD
Zaleplon—Malaise—Betamethasone—psoriasis	9.77e-05	0.000272	CcSEcCtD
Zaleplon—Anaphylactic shock—Triamcinolone—psoriasis	9.75e-05	0.000271	CcSEcCtD
Zaleplon—Oedema—Triamcinolone—psoriasis	9.75e-05	0.000271	CcSEcCtD
Zaleplon—Vertigo—Dexamethasone—psoriasis	9.74e-05	0.000271	CcSEcCtD
Zaleplon—Vertigo—Betamethasone—psoriasis	9.74e-05	0.000271	CcSEcCtD
Zaleplon—Syncope—Dexamethasone—psoriasis	9.72e-05	0.00027	CcSEcCtD
Zaleplon—Syncope—Betamethasone—psoriasis	9.72e-05	0.00027	CcSEcCtD
Zaleplon—Pain—Mycophenolate mofetil—psoriasis	9.72e-05	0.00027	CcSEcCtD
Zaleplon—Constipation—Mycophenolate mofetil—psoriasis	9.72e-05	0.00027	CcSEcCtD
Zaleplon—Sweating—Methotrexate—psoriasis	9.68e-05	0.000269	CcSEcCtD
Zaleplon—Hypotension—Hydrocortisone—psoriasis	9.67e-05	0.000269	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—psoriasis	9.62e-05	0.000268	CcSEcCtD
Zaleplon—Feeling abnormal—Cyclosporine—psoriasis	9.6e-05	0.000267	CcSEcCtD
Zaleplon—Shock—Triamcinolone—psoriasis	9.59e-05	0.000267	CcSEcCtD
Zaleplon—Insomnia—Prednisolone—psoriasis	9.59e-05	0.000267	CcSEcCtD
Zaleplon—Alopecia—Prednisone—psoriasis	9.58e-05	0.000266	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—psoriasis	9.54e-05	0.000265	CcSEcCtD
Zaleplon—Gastrointestinal pain—Cyclosporine—psoriasis	9.52e-05	0.000265	CcSEcCtD
Zaleplon—Loss of consciousness—Betamethasone—psoriasis	9.52e-05	0.000265	CcSEcCtD
Zaleplon—Loss of consciousness—Dexamethasone—psoriasis	9.52e-05	0.000265	CcSEcCtD
Zaleplon—Dizziness—Mycophenolic acid—psoriasis	9.52e-05	0.000265	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—psoriasis	9.52e-05	0.000265	CcSEcCtD
Zaleplon—Paraesthesia—Prednisolone—psoriasis	9.52e-05	0.000265	CcSEcCtD
Zaleplon—Tachycardia—Triamcinolone—psoriasis	9.51e-05	0.000264	CcSEcCtD
Zaleplon—Mental disorder—Prednisone—psoriasis	9.5e-05	0.000264	CcSEcCtD
Zaleplon—Malnutrition—Prednisone—psoriasis	9.44e-05	0.000262	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.43e-05	0.000262	CcSEcCtD
Zaleplon—Hyperhidrosis—Triamcinolone—psoriasis	9.42e-05	0.000262	CcSEcCtD
Zaleplon—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.36e-05	0.00026	CcSEcCtD
Zaleplon—Insomnia—Hydrocortisone—psoriasis	9.36e-05	0.00026	CcSEcCtD
Zaleplon—Hypertension—Dexamethasone—psoriasis	9.36e-05	0.00026	CcSEcCtD
Zaleplon—Hypertension—Betamethasone—psoriasis	9.36e-05	0.00026	CcSEcCtD
Zaleplon—Paraesthesia—Hydrocortisone—psoriasis	9.29e-05	0.000258	CcSEcCtD
Zaleplon—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.29e-05	0.000258	CcSEcCtD
Zaleplon—Urticaria—Cyclosporine—psoriasis	9.25e-05	0.000257	CcSEcCtD
Zaleplon—Myalgia—Dexamethasone—psoriasis	9.23e-05	0.000256	CcSEcCtD
Zaleplon—Myalgia—Betamethasone—psoriasis	9.23e-05	0.000256	CcSEcCtD
Zaleplon—Abdominal pain—Cyclosporine—psoriasis	9.21e-05	0.000256	CcSEcCtD
Zaleplon—Body temperature increased—Cyclosporine—psoriasis	9.21e-05	0.000256	CcSEcCtD
Zaleplon—Anxiety—Betamethasone—psoriasis	9.19e-05	0.000256	CcSEcCtD
Zaleplon—Anxiety—Dexamethasone—psoriasis	9.19e-05	0.000256	CcSEcCtD
Zaleplon—Discomfort—Betamethasone—psoriasis	9.11e-05	0.000253	CcSEcCtD
Zaleplon—Discomfort—Dexamethasone—psoriasis	9.11e-05	0.000253	CcSEcCtD
Zaleplon—Dyspepsia—Hydrocortisone—psoriasis	9.11e-05	0.000253	CcSEcCtD
Zaleplon—Rash—Mycophenolic acid—psoriasis	9.08e-05	0.000252	CcSEcCtD
Zaleplon—Dermatitis—Mycophenolic acid—psoriasis	9.07e-05	0.000252	CcSEcCtD
Zaleplon—Pain—Prednisolone—psoriasis	9.06e-05	0.000252	CcSEcCtD
Zaleplon—Urticaria—Mycophenolate mofetil—psoriasis	9.03e-05	0.000251	CcSEcCtD
Zaleplon—Headache—Mycophenolic acid—psoriasis	9.02e-05	0.000251	CcSEcCtD
Zaleplon—Decreased appetite—Hydrocortisone—psoriasis	9e-05	0.00025	CcSEcCtD
Zaleplon—Abdominal pain—Mycophenolate mofetil—psoriasis	8.98e-05	0.00025	CcSEcCtD
Zaleplon—Body temperature increased—Mycophenolate mofetil—psoriasis	8.98e-05	0.00025	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.94e-05	0.000248	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.88e-05	0.000247	CcSEcCtD
Zaleplon—Pain—Hydrocortisone—psoriasis	8.85e-05	0.000246	CcSEcCtD
Zaleplon—Anaphylactic shock—Betamethasone—psoriasis	8.84e-05	0.000246	CcSEcCtD
Zaleplon—Oedema—Betamethasone—psoriasis	8.84e-05	0.000246	CcSEcCtD
Zaleplon—Oedema—Dexamethasone—psoriasis	8.84e-05	0.000246	CcSEcCtD
Zaleplon—Anaphylactic shock—Dexamethasone—psoriasis	8.84e-05	0.000246	CcSEcCtD
Zaleplon—Insomnia—Triamcinolone—psoriasis	8.82e-05	0.000245	CcSEcCtD
Zaleplon—Ill-defined disorder—Prednisone—psoriasis	8.76e-05	0.000243	CcSEcCtD
Zaleplon—Paraesthesia—Triamcinolone—psoriasis	8.75e-05	0.000243	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisolone—psoriasis	8.73e-05	0.000243	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—psoriasis	8.73e-05	0.000243	CcSEcCtD
Zaleplon—Anaemia—Prednisone—psoriasis	8.72e-05	0.000242	CcSEcCtD
Zaleplon—Shock—Dexamethasone—psoriasis	8.7e-05	0.000242	CcSEcCtD
Zaleplon—Shock—Betamethasone—psoriasis	8.7e-05	0.000242	CcSEcCtD
Zaleplon—Dyspnoea—Triamcinolone—psoriasis	8.69e-05	0.000242	CcSEcCtD
Zaleplon—Nervous system disorder—Dexamethasone—psoriasis	8.67e-05	0.000241	CcSEcCtD
Zaleplon—Nervous system disorder—Betamethasone—psoriasis	8.67e-05	0.000241	CcSEcCtD
Zaleplon—Agitation—Prednisone—psoriasis	8.67e-05	0.000241	CcSEcCtD
Zaleplon—Tachycardia—Dexamethasone—psoriasis	8.63e-05	0.00024	CcSEcCtD
Zaleplon—Tachycardia—Betamethasone—psoriasis	8.63e-05	0.00024	CcSEcCtD
Zaleplon—Angioedema—Prednisone—psoriasis	8.62e-05	0.00024	CcSEcCtD
Zaleplon—Dyspepsia—Triamcinolone—psoriasis	8.58e-05	0.000239	CcSEcCtD
Zaleplon—Nausea—Mycophenolic acid—psoriasis	8.55e-05	0.000238	CcSEcCtD
Zaleplon—Hyperhidrosis—Dexamethasone—psoriasis	8.55e-05	0.000238	CcSEcCtD
Zaleplon—Hyperhidrosis—Betamethasone—psoriasis	8.55e-05	0.000238	CcSEcCtD
Zaleplon—Feeling abnormal—Hydrocortisone—psoriasis	8.53e-05	0.000237	CcSEcCtD
Zaleplon—Malaise—Prednisone—psoriasis	8.51e-05	0.000237	CcSEcCtD
Zaleplon—Vertigo—Prednisone—psoriasis	8.48e-05	0.000236	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—psoriasis	8.47e-05	0.000235	CcSEcCtD
Zaleplon—Gastrointestinal pain—Hydrocortisone—psoriasis	8.46e-05	0.000235	CcSEcCtD
Zaleplon—Syncope—Prednisone—psoriasis	8.46e-05	0.000235	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—psoriasis	8.45e-05	0.000235	CcSEcCtD
Zaleplon—Anorexia—Dexamethasone—psoriasis	8.43e-05	0.000234	CcSEcCtD
Zaleplon—Anorexia—Betamethasone—psoriasis	8.43e-05	0.000234	CcSEcCtD
Zaleplon—Urticaria—Prednisolone—psoriasis	8.42e-05	0.000234	CcSEcCtD
Zaleplon—Asthenia—Cyclosporine—psoriasis	8.36e-05	0.000232	CcSEcCtD
Zaleplon—Pain—Triamcinolone—psoriasis	8.33e-05	0.000232	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisone—psoriasis	8.29e-05	0.000231	CcSEcCtD
Zaleplon—Hypotension—Betamethasone—psoriasis	8.26e-05	0.00023	CcSEcCtD
Zaleplon—Hypotension—Dexamethasone—psoriasis	8.26e-05	0.00023	CcSEcCtD
Zaleplon—Pruritus—Cyclosporine—psoriasis	8.24e-05	0.000229	CcSEcCtD
Zaleplon—Urticaria—Hydrocortisone—psoriasis	8.22e-05	0.000229	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—psoriasis	8.18e-05	0.000228	CcSEcCtD
Zaleplon—Abdominal pain—Hydrocortisone—psoriasis	8.18e-05	0.000228	CcSEcCtD
Zaleplon—Body temperature increased—Hydrocortisone—psoriasis	8.18e-05	0.000228	CcSEcCtD
Zaleplon—Asthenia—Mycophenolate mofetil—psoriasis	8.15e-05	0.000227	CcSEcCtD
Zaleplon—Hypertension—Prednisone—psoriasis	8.15e-05	0.000227	CcSEcCtD
Zaleplon—Chills—Methotrexate—psoriasis	8.13e-05	0.000226	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.06e-05	0.000224	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Betamethasone—psoriasis	8.06e-05	0.000224	CcSEcCtD
Zaleplon—Pruritus—Mycophenolate mofetil—psoriasis	8.04e-05	0.000223	CcSEcCtD
Zaleplon—Myalgia—Prednisone—psoriasis	8.03e-05	0.000223	CcSEcCtD
Zaleplon—Arthralgia—Prednisone—psoriasis	8.03e-05	0.000223	CcSEcCtD
Zaleplon—Feeling abnormal—Triamcinolone—psoriasis	8.03e-05	0.000223	CcSEcCtD
Zaleplon—Anxiety—Prednisone—psoriasis	8.01e-05	0.000223	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—psoriasis	8.01e-05	0.000223	CcSEcCtD
Zaleplon—Insomnia—Betamethasone—psoriasis	8e-05	0.000222	CcSEcCtD
Zaleplon—Insomnia—Dexamethasone—psoriasis	8e-05	0.000222	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.98e-05	0.000222	CcSEcCtD
Zaleplon—Paraesthesia—Betamethasone—psoriasis	7.94e-05	0.000221	CcSEcCtD
Zaleplon—Paraesthesia—Dexamethasone—psoriasis	7.94e-05	0.000221	CcSEcCtD
Zaleplon—Discomfort—Prednisone—psoriasis	7.94e-05	0.000221	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—psoriasis	7.94e-05	0.000221	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—psoriasis	7.89e-05	0.000219	CcSEcCtD
Zaleplon—Dyspepsia—Betamethasone—psoriasis	7.78e-05	0.000216	CcSEcCtD
Zaleplon—Dyspepsia—Dexamethasone—psoriasis	7.78e-05	0.000216	CcSEcCtD
Zaleplon—Urticaria—Triamcinolone—psoriasis	7.74e-05	0.000215	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—psoriasis	7.72e-05	0.000215	CcSEcCtD
Zaleplon—Body temperature increased—Triamcinolone—psoriasis	7.7e-05	0.000214	CcSEcCtD
Zaleplon—Dizziness—Cyclosporine—psoriasis	7.7e-05	0.000214	CcSEcCtD
Zaleplon—Oedema—Prednisone—psoriasis	7.7e-05	0.000214	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—psoriasis	7.7e-05	0.000214	CcSEcCtD
Zaleplon—Decreased appetite—Dexamethasone—psoriasis	7.69e-05	0.000214	CcSEcCtD
Zaleplon—Decreased appetite—Betamethasone—psoriasis	7.69e-05	0.000214	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Dexamethasone—psoriasis	7.64e-05	0.000212	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Betamethasone—psoriasis	7.64e-05	0.000212	CcSEcCtD
Zaleplon—Back pain—Methotrexate—psoriasis	7.63e-05	0.000212	CcSEcCtD
Zaleplon—Shock—Prednisone—psoriasis	7.58e-05	0.000211	CcSEcCtD
Zaleplon—Pain—Dexamethasone—psoriasis	7.56e-05	0.00021	CcSEcCtD
Zaleplon—Pain—Betamethasone—psoriasis	7.56e-05	0.00021	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—psoriasis	7.55e-05	0.00021	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—psoriasis	7.52e-05	0.000209	CcSEcCtD
Zaleplon—Dizziness—Mycophenolate mofetil—psoriasis	7.51e-05	0.000209	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—psoriasis	7.48e-05	0.000208	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisone—psoriasis	7.45e-05	0.000207	CcSEcCtD
Zaleplon—Asthenia—Hydrocortisone—psoriasis	7.43e-05	0.000206	CcSEcCtD
Zaleplon—Rash—Cyclosporine—psoriasis	7.34e-05	0.000204	CcSEcCtD
Zaleplon—Anorexia—Prednisone—psoriasis	7.34e-05	0.000204	CcSEcCtD
Zaleplon—Dermatitis—Cyclosporine—psoriasis	7.34e-05	0.000204	CcSEcCtD
Zaleplon—Pruritus—Hydrocortisone—psoriasis	7.32e-05	0.000204	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—psoriasis	7.32e-05	0.000203	CcSEcCtD
Zaleplon—Headache—Cyclosporine—psoriasis	7.3e-05	0.000203	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—psoriasis	7.29e-05	0.000203	CcSEcCtD
Zaleplon—Feeling abnormal—Dexamethasone—psoriasis	7.29e-05	0.000203	CcSEcCtD
Zaleplon—Feeling abnormal—Betamethasone—psoriasis	7.29e-05	0.000203	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dexamethasone—psoriasis	7.23e-05	0.000201	CcSEcCtD
Zaleplon—Gastrointestinal pain—Betamethasone—psoriasis	7.23e-05	0.000201	CcSEcCtD
Zaleplon—Rash—Mycophenolate mofetil—psoriasis	7.16e-05	0.000199	CcSEcCtD
Zaleplon—Dermatitis—Mycophenolate mofetil—psoriasis	7.16e-05	0.000199	CcSEcCtD
Zaleplon—Headache—Mycophenolate mofetil—psoriasis	7.12e-05	0.000198	CcSEcCtD
Zaleplon—Malaise—Methotrexate—psoriasis	7.11e-05	0.000198	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—psoriasis	7.09e-05	0.000197	CcSEcCtD
Zaleplon—Urticaria—Betamethasone—psoriasis	7.03e-05	0.000195	CcSEcCtD
Zaleplon—Urticaria—Dexamethasone—psoriasis	7.03e-05	0.000195	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Prednisone—psoriasis	7.02e-05	0.000195	CcSEcCtD
Zaleplon—Dizziness—Prednisolone—psoriasis	7.01e-05	0.000195	CcSEcCtD
Zaleplon—Asthenia—Triamcinolone—psoriasis	6.99e-05	0.000194	CcSEcCtD
Zaleplon—Abdominal pain—Betamethasone—psoriasis	6.99e-05	0.000194	CcSEcCtD
Zaleplon—Body temperature increased—Betamethasone—psoriasis	6.99e-05	0.000194	CcSEcCtD
Zaleplon—Abdominal pain—Dexamethasone—psoriasis	6.99e-05	0.000194	CcSEcCtD
Zaleplon—Body temperature increased—Dexamethasone—psoriasis	6.99e-05	0.000194	CcSEcCtD
Zaleplon—Insomnia—Prednisone—psoriasis	6.97e-05	0.000194	CcSEcCtD
Zaleplon—Nausea—Cyclosporine—psoriasis	6.92e-05	0.000192	CcSEcCtD
Zaleplon—Paraesthesia—Prednisone—psoriasis	6.92e-05	0.000192	CcSEcCtD
Zaleplon—Pruritus—Triamcinolone—psoriasis	6.9e-05	0.000192	CcSEcCtD
Zaleplon—Dizziness—Hydrocortisone—psoriasis	6.84e-05	0.00019	CcSEcCtD
Zaleplon—Dyspepsia—Prednisone—psoriasis	6.78e-05	0.000188	CcSEcCtD
Zaleplon—Nausea—Mycophenolate mofetil—psoriasis	6.75e-05	0.000188	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—psoriasis	6.71e-05	0.000187	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—psoriasis	6.71e-05	0.000187	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—psoriasis	6.71e-05	0.000187	CcSEcCtD
Zaleplon—Decreased appetite—Prednisone—psoriasis	6.7e-05	0.000186	CcSEcCtD
Zaleplon—Rash—Prednisolone—psoriasis	6.68e-05	0.000186	CcSEcCtD
Zaleplon—Dermatitis—Prednisolone—psoriasis	6.68e-05	0.000186	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.67e-05	0.000185	CcSEcCtD
Zaleplon—Headache—Prednisolone—psoriasis	6.64e-05	0.000185	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—psoriasis	6.63e-05	0.000184	CcSEcCtD
Zaleplon—Constipation—Prednisone—psoriasis	6.59e-05	0.000183	CcSEcCtD
Zaleplon—Rash—Hydrocortisone—psoriasis	6.53e-05	0.000181	CcSEcCtD
Zaleplon—Dermatitis—Hydrocortisone—psoriasis	6.52e-05	0.000181	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—psoriasis	6.49e-05	0.00018	CcSEcCtD
Zaleplon—Headache—Hydrocortisone—psoriasis	6.48e-05	0.00018	CcSEcCtD
Zaleplon—Dizziness—Triamcinolone—psoriasis	6.45e-05	0.000179	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—psoriasis	6.44e-05	0.000179	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisone—psoriasis	6.35e-05	0.000176	CcSEcCtD
Zaleplon—Asthenia—Betamethasone—psoriasis	6.35e-05	0.000176	CcSEcCtD
Zaleplon—Asthenia—Dexamethasone—psoriasis	6.35e-05	0.000176	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—psoriasis	6.31e-05	0.000175	CcSEcCtD
Zaleplon—Gastrointestinal pain—Prednisone—psoriasis	6.3e-05	0.000175	CcSEcCtD
Zaleplon—Nausea—Prednisolone—psoriasis	6.3e-05	0.000175	CcSEcCtD
Zaleplon—Pruritus—Dexamethasone—psoriasis	6.26e-05	0.000174	CcSEcCtD
Zaleplon—Pruritus—Betamethasone—psoriasis	6.26e-05	0.000174	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—psoriasis	6.25e-05	0.000174	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—psoriasis	6.22e-05	0.000173	CcSEcCtD
Zaleplon—Nausea—Hydrocortisone—psoriasis	6.15e-05	0.000171	CcSEcCtD
Zaleplon—Rash—Triamcinolone—psoriasis	6.15e-05	0.000171	CcSEcCtD
Zaleplon—Dermatitis—Triamcinolone—psoriasis	6.14e-05	0.000171	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—psoriasis	6.14e-05	0.000171	CcSEcCtD
Zaleplon—Urticaria—Prednisone—psoriasis	6.12e-05	0.00017	CcSEcCtD
Zaleplon—Headache—Triamcinolone—psoriasis	6.11e-05	0.00017	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—psoriasis	6.09e-05	0.000169	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—psoriasis	6.09e-05	0.000169	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—psoriasis	6.01e-05	0.000167	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—psoriasis	5.86e-05	0.000163	CcSEcCtD
Zaleplon—Dizziness—Dexamethasone—psoriasis	5.85e-05	0.000163	CcSEcCtD
Zaleplon—Dizziness—Betamethasone—psoriasis	5.85e-05	0.000163	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—psoriasis	5.82e-05	0.000162	CcSEcCtD
Zaleplon—Nausea—Triamcinolone—psoriasis	5.79e-05	0.000161	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—psoriasis	5.78e-05	0.000161	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—psoriasis	5.74e-05	0.00016	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—psoriasis	5.72e-05	0.000159	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—psoriasis	5.67e-05	0.000158	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—psoriasis	5.6e-05	0.000156	CcSEcCtD
Zaleplon—Rash—Dexamethasone—psoriasis	5.58e-05	0.000155	CcSEcCtD
Zaleplon—Rash—Betamethasone—psoriasis	5.58e-05	0.000155	CcSEcCtD
Zaleplon—Dermatitis—Dexamethasone—psoriasis	5.57e-05	0.000155	CcSEcCtD
Zaleplon—Dermatitis—Betamethasone—psoriasis	5.57e-05	0.000155	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—psoriasis	5.56e-05	0.000154	CcSEcCtD
Zaleplon—Headache—Betamethasone—psoriasis	5.54e-05	0.000154	CcSEcCtD
Zaleplon—Headache—Dexamethasone—psoriasis	5.54e-05	0.000154	CcSEcCtD
Zaleplon—Asthenia—Prednisone—psoriasis	5.53e-05	0.000154	CcSEcCtD
Zaleplon—Pain—Methotrexate—psoriasis	5.5e-05	0.000153	CcSEcCtD
Zaleplon—Pruritus—Prednisone—psoriasis	5.45e-05	0.000151	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—psoriasis	5.3e-05	0.000147	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—psoriasis	5.26e-05	0.000146	CcSEcCtD
Zaleplon—Nausea—Dexamethasone—psoriasis	5.25e-05	0.000146	CcSEcCtD
Zaleplon—Nausea—Betamethasone—psoriasis	5.25e-05	0.000146	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—psoriasis	5.11e-05	0.000142	CcSEcCtD
Zaleplon—Dizziness—Prednisone—psoriasis	5.09e-05	0.000142	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—psoriasis	5.09e-05	0.000141	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—psoriasis	5.09e-05	0.000141	CcSEcCtD
Zaleplon—Rash—Prednisone—psoriasis	4.86e-05	0.000135	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—psoriasis	4.85e-05	0.000135	CcSEcCtD
Zaleplon—Headache—Prednisone—psoriasis	4.82e-05	0.000134	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—psoriasis	4.62e-05	0.000128	CcSEcCtD
Zaleplon—Nausea—Prednisone—psoriasis	4.57e-05	0.000127	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—psoriasis	4.55e-05	0.000127	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—psoriasis	4.26e-05	0.000118	CcSEcCtD
Zaleplon—Rash—Methotrexate—psoriasis	4.06e-05	0.000113	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—psoriasis	4.05e-05	0.000113	CcSEcCtD
Zaleplon—Headache—Methotrexate—psoriasis	4.03e-05	0.000112	CcSEcCtD
Zaleplon—Nausea—Methotrexate—psoriasis	3.82e-05	0.000106	CcSEcCtD
